Loading...
You are here:  Home  >  Health  >  Current News

Roche’s Tecentriq wins FDA approval for treating advanced bladder cancer



(Reuters) - Genentech, a unit of Swiss drugmaker Roche Holding AG, said on Monday it got approval from the U.S. Food and Drug Administration for its already approved immunotherapy drug, Tecentriq, to treat advanced bladder cancer.


Other News

India says it is committed to global tobacco-control treaty NEW DELHI (Reuters) - India reaffirmed on Tuesday its commitment to a World Health Organization (WHO) tobacco-control treaty, despite lobbying from ...
Sanofi, DiCE Molecules announce drug partnership PARIS (Reuters) - French drugmaker Sanofi and privately held DiCE Molecules announced on Wednesday a five-year research partnership aimed at discove...
Scottish nurse who had Ebola cleared of hiding symptom EDINBURGH (Reuters) - A Scottish nurse who contracted Ebola while caring for patients in Sierra Leone was cleared on Wednesday of allegations that s...

Found news:

Loading...

You might also like...

Health insurers says Senate bill’s Medicaid cuts to hurt states

Read More →